Invest in 10,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
LeMaitre Vascular, Inc. develops, manufactures, and markets medical devices and implants used in the field of vascular surgery worldwide. It offers human cadaver tissue cryopreservation services; angioscope, a fiberoptic catheter used for viewing the lumen of a blood vessel; embolectomy catheters to remove blood clots from arteries; thrombectomy catheters for removing thrombi in the venous system; occlusion catheters that temporarily occlude the blood flow; and perfusion catheters to perfuse the blood and other fluids into the vasculature. The company also provides artegraft biologic graft, a bovine carotid artery used for dialysis access; XenoSure biologic patches, used for closure of vessels after surgical intervention; VascuCel and CardioCel biologic patches, used in vessel repair, heart repair and reconstruction, and neonatal repairs; cardiovascular patches; carotid shunts that temporarily shunt the blood to the brain during the removal of plaque in a carotid endarterectomy surgery; biosynthetic vascular graft indicated for lower extremity bypass and dialysis access; and vascular grafts used to bypass or replace diseased arteries. In addition, it offers radiopaque tape, a medical-grade tape applied to the skin that enables surgeons and interventionalists to cross-refer between the inside and the outside of a patient's body and allows them to locate tributaries or lesions beneath the skin. Further, the company provides valvulotomes, which cut or disrupt valves in the saphenous vein to function as an artery to carry blood past diseased arteries to the lower leg or the foot; and closure systems to attach vessels to one another with titanium clips instead of sutures. It markets its products through a direct sales force and distributors. The company was formerly known as Vascutech, Inc. and changed its name to LeMaitre Vascular, Inc. in April 2001. LeMaitre Vascular, Inc. was incorporated in 1983 and is headquartered in Burlington, Massachusetts. more
Time Frame | LMAT | Sector | S&P500 |
---|---|---|---|
1-Week Return | -0.43% | -2.27% | -0.57% |
1-Month Return | -1.83% | -3.96% | 1.21% |
3-Month Return | 12.26% | -9.7% | 7.57% |
6-Month Return | 27.38% | -3.37% | 11.45% |
1-Year Return | 85.84% | 3.71% | 28.48% |
3-Year Return | 108.55% | 3.8% | 29.52% |
5-Year Return | 183% | 39.78% | 90.66% |
10-Year Return | 1298.47% | 106.91% | 203.75% |
Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | 5YR TREND | |
---|---|---|---|---|---|---|
Total Revenue | 117.23M | 129.37M | 154.42M | 161.65M | 193.48M | [{"date":"2019-12-31","value":60.59,"profit":true},{"date":"2020-12-31","value":66.86,"profit":true},{"date":"2021-12-31","value":79.81,"profit":true},{"date":"2022-12-31","value":83.55,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Cost of Revenue | 37.38M | 44.75M | 53.04M | 56.76M | 66.44M | [{"date":"2019-12-31","value":56.26,"profit":true},{"date":"2020-12-31","value":67.36,"profit":true},{"date":"2021-12-31","value":79.84,"profit":true},{"date":"2022-12-31","value":85.43,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Gross Profit | 79.85M | 84.62M | 101.38M | 104.90M | 127.05M | [{"date":"2019-12-31","value":62.85,"profit":true},{"date":"2020-12-31","value":66.6,"profit":true},{"date":"2021-12-31","value":79.8,"profit":true},{"date":"2022-12-31","value":82.56,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Gross Margin | 68.12% | 65.41% | 65.65% | 64.89% | 65.66% | [{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":96.03,"profit":true},{"date":"2021-12-31","value":96.38,"profit":true},{"date":"2022-12-31","value":95.27,"profit":true},{"date":"2023-12-31","value":96.4,"profit":true}] |
Operating Expenses | 58.67M | 56.30M | 64.96M | 74.96M | 90.34M | [{"date":"2019-12-31","value":64.95,"profit":true},{"date":"2020-12-31","value":62.32,"profit":true},{"date":"2021-12-31","value":71.91,"profit":true},{"date":"2022-12-31","value":82.98,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Operating Income | 15.77M | 19.80M | 25.55M | 21.16M | 37.08M | [{"date":"2019-12-31","value":42.52,"profit":true},{"date":"2020-12-31","value":53.4,"profit":true},{"date":"2021-12-31","value":68.91,"profit":true},{"date":"2022-12-31","value":57.07,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Total Non-Operating Income/Expense | 6.61M | (2.74M) | (4.16M) | 1.65M | 4.92M | [{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":-41.48,"profit":false},{"date":"2021-12-31","value":-62.93,"profit":false},{"date":"2022-12-31","value":24.92,"profit":true},{"date":"2023-12-31","value":74.51,"profit":true}] |
Pre-Tax Income | 21.68M | 27.36M | 34.29M | 27.49M | 39.48M | [{"date":"2019-12-31","value":54.92,"profit":true},{"date":"2020-12-31","value":69.3,"profit":true},{"date":"2021-12-31","value":86.86,"profit":true},{"date":"2022-12-31","value":69.64,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Income Taxes | 3.75M | 6.14M | 7.38M | 6.85M | 9.37M | [{"date":"2019-12-31","value":39.97,"profit":true},{"date":"2020-12-31","value":65.49,"profit":true},{"date":"2021-12-31","value":78.76,"profit":true},{"date":"2022-12-31","value":73.15,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Income After Taxes | 17.93M | 21.22M | 26.91M | 20.64M | 30.11M | [{"date":"2019-12-31","value":59.57,"profit":true},{"date":"2020-12-31","value":70.49,"profit":true},{"date":"2021-12-31","value":89.38,"profit":true},{"date":"2022-12-31","value":68.55,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Income From Continuous Operations | 17.93M | 21.22M | 26.91M | 20.64M | 27.27M | [{"date":"2019-12-31","value":65.77,"profit":true},{"date":"2020-12-31","value":77.82,"profit":true},{"date":"2021-12-31","value":98.68,"profit":true},{"date":"2022-12-31","value":75.68,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Income From Discontinued Operations | - | - | - | - | - | [{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}] |
Net Income | 17.93M | 21.22M | 26.91M | 20.64M | 30.11M | [{"date":"2019-12-31","value":59.57,"profit":true},{"date":"2020-12-31","value":70.49,"profit":true},{"date":"2021-12-31","value":89.38,"profit":true},{"date":"2022-12-31","value":68.55,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
EPS (Diluted) | 0.88 | 1.08 | 1.26 | 0.93 | 1.34 | [{"date":"2019-12-31","value":65.67,"profit":true},{"date":"2020-12-31","value":80.6,"profit":true},{"date":"2021-12-31","value":94.03,"profit":true},{"date":"2022-12-31","value":69.4,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
These ratios help you determine the liquidity of the company. Higher is better.
LMAT | |
---|---|
Cash Ratio | 4.22 |
Current Ratio | 7.74 |
Quick Ratio | 5.52 |
These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.
LMAT | |
---|---|
ROA (LTM) | 8.72% |
ROE (LTM) | 13.34% |
These ratios help you understand the company's liabilities, gauging the riskiness of the investment.
LMAT | |
---|---|
Debt Ratio Lower is generally better. Negative is bad. | 0.12 |
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. | 0.88 |
These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.
LMAT | |
---|---|
Trailing PE | 55.32 |
Forward PE | 46.30 |
P/S (TTM) | 10.70 |
P/B | 6.81 |
Price/FCF | 181 |
EV/R | 10.09 |
EV/Ebitda | 34.93 |
PEG | 2.20 |
LeMaitre Vascular Inc (LMAT) share price today is $100.69
Yes, Indians can buy shares of LeMaitre Vascular Inc (LMAT) on Vested. To buy LeMaitre Vascular Inc from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in LMAT stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.
Yes, you can purchase fractional shares of LeMaitre Vascular Inc (LMAT) via the Vested app. You can start investing in LeMaitre Vascular Inc (LMAT) with a minimum investment of $1.
You can invest in shares of LeMaitre Vascular Inc (LMAT) via Vested in three simple steps:
The 52-week high price of LeMaitre Vascular Inc (LMAT) is $109.58. The 52-week low price of LeMaitre Vascular Inc (LMAT) is $52.46.
The price-to-earnings (P/E) ratio of LeMaitre Vascular Inc (LMAT) is 55.4033
The price-to-book (P/B) ratio of LeMaitre Vascular Inc (LMAT) is 6.81
The dividend yield of LeMaitre Vascular Inc (LMAT) is 0.64%
The market capitalization of LeMaitre Vascular Inc (LMAT) is $2.27B
The stock symbol (or ticker) of LeMaitre Vascular Inc is LMAT